Weight Loss Drugs Reshape Industry and Health Debates

The rising popularity of weight loss drugs such as Ozempic and Mounjaro has led to a decline in traditional slimming clubs and contributed to companies like Weight Watchers facing bankruptcy. GLP-1 agonists have enabled many to achieve rapid weight loss by reducing appetite, but users report side effects ranging from nausea and fatigue to more serious health risks, leading health officials to advise the drugs be used only under medical supervision. Some, including NHS nurse Rhianna Berry, have chosen alternatives like bariatric surgery due to injection side effects, while others have experienced public criticism for dramatic weight loss. Personal stories reveal both the transformative and challenging aspects of these medications, including discomfort and complex psychological effects. Experts stress the need for responsible use and ongoing monitoring. The shift toward medication-based solutions marks a significant change in societal approaches to weight management.